Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor. (Q42807800)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

main subject

endometrial carcinoma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Zheng Tu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Liming Gui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Jianliu Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Xiaoping Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Lihui Wei

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

21 November 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

274-279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16303170%20AND%20SRC:MED&resulttype=core&format=json

NMR characterization of full-length farnesylated and non-farnesylated H-Ras and its implications for Raf activation

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

K-ras point mutations in spontaneously occurring endometrial adenocarcinomas in the Donryu rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

A novel activating mutation of the K-ras gene in human primary colon adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Activated K-ras is involved in regulation of integrin expression in human colon carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

From pancreatic intraepithelial neoplasia to cancer: a dramatic progression with K-ras status analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Genetic alterations in gallbladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Immunohistochemical analysis of MIB-1 proliferative activity in human endometrial cancer. Correlation with clinicopathological parameters, patient outcome, retinoblastoma immunoreactivity and K-ras codon 12 point mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Essential role of p38gamma in K-Ras transformation independent of phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Mutant K-rasV12 increases COX-2, peroxides and DNA damage in lung cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Comparison of macroscopic appearance and estrogen receptor-alpha regulators after gene alteration in human endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Endometrial K-ras mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

K‐ras mutation in tamoxifen‐related endometrial polyps

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Steroid receptors and metastatic potential in endometrial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Stress kinase signaling in cancer: fact or fiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016

Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.10.016